Sotera Health Co
NASDAQ:SHC
Sotera Health Co
Accounts Receivables
Sotera Health Co
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sotera Health Co
NASDAQ:SHC
|
Accounts Receivables
$165.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accounts Receivables
$9.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accounts Receivables
$650.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
Agilent Technologies Inc
NYSE:A
|
Accounts Receivables
$1.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
See Also
What is Sotera Health Co's Accounts Receivables?
Accounts Receivables
165.5m
USD
Based on the financial report for Dec 31, 2023, Sotera Health Co's Accounts Receivables amounts to 165.5m USD.
What is Sotera Health Co's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
11%
Over the last year, the Accounts Receivables growth was 20%. The average annual Accounts Receivables growth rates for Sotera Health Co have been 22% over the past three years , 11% over the past five years .